G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
Abstract Background The incidence of malaria in the Americas has decreased markedly in recent years. Honduras and the other countries of Mesoamerica and the island of Hispaniola have set the goal of eliminating native malaria by the year 2020. To achieve this goal, Honduras has recently approved nat...
Main Authors: | Sara Avalos, Rosa E. Mejia, Engels Banegas, Cesar Salinas, Lester Gutierrez, Marcela Fajardo, Suzeth Galo, Alejandra Pinto, Angel Mejia, Gustavo Fontecha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-018-2564-2 |
Similar Items
-
Modelling primaquine-induced haemolysis in G6PD deficiency
by: James Watson, et al.
Published: (2017-02-01) -
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
by: Germana Bancone, et al.
Published: (2021-03-01) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2018-03-01) -
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Robert J. Commons, et al.
Published: (2019-08-01) -
G6PD deficiency in Latin America: systematic review on prevalence and variants
by: Wuelton M Monteiro, et al.
Published: (2014-08-01)